Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Net Asset Value

27 Oct 2008 07:00

RNS Number : 6911G
Fabian Romania Limited
27 October 2008
 



27 October 2008

Fabian Romania Limited (FAB.LN)

Net asset value as at 30 September 2008

Fabian Romania Limited ("Fabian"), the AIM listed dedicated investor in the Bucharest and wider Romanian real estate market announces its Net Asset Value ("NAV") as at 30 September 2008.

Fabian seeks to generate attractive total returns for its shareholders through a portfolio of income producing buildings, co-development residential, office, logistics and retail projects, with experienced partners and land investments. Fabian receives investment advice from Fabian Capital Limited, an independent investment management firm that specialises in Romanian real estate investment advice (Fabian Capital Limited does not carry out any regulated activities in the UK).

 

Highlights

At 30 September 2008 the NAV per share of Fabian as determined in accordance with its Articles of Association was €1.665 per share (30 June 2008: €1.667), decrease of 0.1 per cent. in the third quarter of 2008, practically unchanged from the 31 December 2007 NAV of €1.666 and an increase of 3.6 per cent. in the last twelve months (30 September 2007: €1.607). 
Adjusting the current NAV for the estimated future development profits of 0.553 per share indicates a potential future NAV ("Development Profit NAV" or "DPNAV") of €2.218 per share (30 June 2008: €2.319), a decrease of 4.4 per centin the third quarter of 2008an increase of 1.7 per cent. for the year to date (31 December 2007: €2.180) and an increase of 3.5 per cent. in the last twelve months (30 September 2007: €2.142).
The Romanian property market, like other world markets, is now experiencing the effects of the worldwide credit crunch. Accordingly, there have been no investment transactions for valuers, DTZ Echinox ("DTZ"), to provide evidence upon which to base the valuation yields for open market valuations of properties. Therefore there can be no certainty that the yields used in determining the above NAV accurately reflect the current open market.
In calculating the NAV the development projects are included using the value of the land prior to the start of construction, to which the cost of the construction work in progress less any advance payments received is added. Any change in the valuation of the project as determined by DTZ is reflected in the estimated future profitability of the project to be realised on completion. The net value of the company's holdings in development land not yet subject to construction fell €0.3 million or 3.3 per cent. over the quarter.
The value of Fabian's office portfolio, comprising 33.3 per cent. of the company's net assets as at 30 September 2008, was marked down by 2.6 per cent. during the period, resulting in a fall in value of €1.8 million. The negative impact of rising yields was partially offset by a combination of higher actual rents for several buildings as a result of new leases signed during the period as well as higher forecast reversionary rents for other leases. 
In other assets and liabilities, the company benefited from the recognition of a loan receivable of €2.6 million from a joint venture. 
The reduction in the DPNAV reflects higher forecast exit yields on office projects and recognition of actual costs post commencement of construction of Lakeview.
Annual rental income from Fabian's office portfolio increased 3.2 per cent. during the quarter. New leases were signed with existing tenants at Cascades and Baneasa Business Centre resulting in rental income growth of 4.3 per cent. and 4.8 per cent. respectively. 
As a result of the on-going strength of the Bucharest office letting market and despite new leases being signed at higher rents, DTZ now forecast that the company's portfolio of income producing office buildings are now 17.0 per cent. under rented compared to 11.3 per cent. as at 30 June 2008. 
In line with other countries, the availability of bank credit in Romania has now become more difficult. Whilst Romanian GDP grew at an annualised rate of 8.8 per cent in the first half, a number of economists now forecast GDP growth for 2009 of around 4.0 per cent. In the light of an impending slowdown in growth and given current financial market instability, there is less certainty as to the future level of Bucharest office rents for the foreseeable future.
Projects continue to be structured and financed to drive returns albeit in a prudent manner. During September  2008, a bank facility for the Romana office development project was agreed with Bank of Cyprus for both a construction and an investment loan. An initial drawdown is expected in the fourth quarter to repay part of the equity invested to date. Maximum gearing on the construction loan is 83 per cent. of costs while the investment loan is 75 per cent. of the open market value once construction is complete for a further term of 17 years. Construction on the Romana office development project is progressing on schedule and practical completion is expected in the second quarter of 2010.
In August 2008 the Investkredit Bank loan secured on the Cascades office building was successfully refinanced  with a facility of up to €13.875 million from Bank of Cyprus. 68 per cent of the available facility has been drawn down to date with the remaining 32 per cent. available for drawdown in the future.
The maturity profile of the investment loans averages over 10 years. The outstanding project debts requiring refinancing in the near future are the land loan of €2.9 million on the Timisoara residential project, which is expected to be rolled over in December 2008, and on completion of the acquisition of the Cubic Centre, expected in the first quarter of 2009, the developer's existing bank loan of €31 million will either be rolled over with the existing lender or will need to be externally refinanced.
Sales at the New Town residential scheme were slow in the third quarter but now total 285 forward sales. The first phase (315 units) is nearing build completion, anticipated in March 2009, with over 85 per cent. of this phase already forward sold. Sufficient sales in total have now been achieved to enable full drawdown of the construction loan banking facility.
The strategy to develop residential projects in western Romania has been changed to reduce operational and financial risk. Rather than launch the residential schemes in TimisoaraOradea and Satu Mare in the current market, the decision has been taken to delay commencement until residential market conditions are more  favourable. The opportunity will now be taken to amend the building consents, when obtained, to reflect an increased number of construction phases on each scheme thereby reducing risk further and increase the available range of financing options.

  

Net Assets of €1.665 per share 

Fabian's NAV as at 30 September 2008 is €1.665 per share, a decrease of 0.1 per cent. from the second quarter's NAV of €1.667 per share

The published NAV has been calculated consistently in accordance with Fabian's Articles of Association. The income producing buildings are valued based on values as determined by DTZ using estimated market yields. However, in the current market conditions and with a lack of evidence of transactions to provide a comparison, there can be no certainty that the yields used for the valuations will accurately reflect the open market value of the buildings. The development projects are included using the value of the land prior to the start of construction, to which the cost of the construction work in progress less any advance payments received is added. Any change in the valuation of the project as determined by DTZ is reflected in the estimated future profitability of the project to be realised on completion.

An analysis of Fabian's NAV by project is summarised below:

30 September 2008

Fabians' share of Market Value 

Net debt

Net Worth 

Net Equity Invested **

€m

€m

€m

€m

Cascades

18.3

(9.5)

8.8

2.6

Banu

17.5

(8.7)

8.8

2.9

Baneasa Business Centre

28.2

(19.2)

9.0

3.9

Evo

5.2

(3.7)

1.6

1.3

Sub-total

69.2

(41.0)

28.2

10.7

Lakeview *^

16.4

(7.2)

9.2

5.3

Romana

3.2

0.0

3.2

2.9

Cubic Centre 

12.5

0.0

12.5

12.5

New Town * ^

26.6

(11.8)

14.9

5.8

Timisoara * ^

5.7

(2.6)

3.1

1.7

Oradea +

2.2

(0.1)

2.1

2.0

Satu Mare +

0.8

(0.1)

0.7

1.2

Net cash

8.0

Other assets / (liabilities) **

2.8

Total

136.6

(62.8)

84.6

42.0

Shares (#)

50,831,130 

NAVPS (€)

1.665

Movement in Q3 2008

-0.1%

* represents Fabian Romania Limited's share of the development

** Net equity invested comprises the original acquisition equity less amounts repaid through refinancing

^ includes development WIP less advance payments from customers

+ Net debt represents deferred acquisition costs

  Future Development Profit of €0.553 per share

In order to provide transparency to Fabian's shareholders as to the potential level of such future development profits that may accrue, an estimate of these future development profits is given belowThe calculations are based on the DTZ site valuations referred to above, at 30 September 2008 which include estimates of these development profits. These estimates by their very nature are forecasts, relying on future events and accordingly are subject to uncertainty. Shareholders may then choose to discount these profits to estimate their net present value in today's terms based on current market conditions.

The forecast development profit figures are stated gross and do not include all costs that may be incurred by Fabian over the course of the projects (in particular transaction fees and any carried interest payable to the investment manager). The implied share of future development profit figures for the New Town, Timisoara, Oradea and Satu Mare residential schemes and the Cubic Centre, Lakeview, and Romana office schemes, based on Fabian's calculations using DTZ's estimates, is given in the table below:

Project

 

 

Implied Fabian Share of future Development Profit (m) 

Final Year of development *

Lakeview

3.2

2009

Cubic Centre

4.0

2009

New Town

8.5

2010

Romana

1.4

2010

Timisoara

6.0

2011

Satu Mare

1.5

2011

Oradea

 

 

3.5

 2012

NAV contribution (m)

28.1

NAVPS constribution ()

0.553

* Fabian estimates (based on DTZ valuations)

Adding these forecast development profits of €28.1 million or €0.553 per share to the NAV produces what the Directors have called the DPNAV of €2.218 per share. This represents a decrease of 4.4 per cent. from 30 June 2008 DPNAV of €2.319.

 

Mark Holdsworth and Jan-Olof Hansson 

Fabian Capital Limited

27 October 2008

The directors of Fabian Romania Limited accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the directors of the Company (who have taken all reasonable care to ensure that such is the case) the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

Contacts: 

Fabian Capital Limited

Mark Holdsworth

Tel: +44 20 7499 9988

Monument PR - Financial Public Relations to Fabian

Toby Moore

Tel: +44 845 355 1178

Deloitte Corporate Finance - Nominated Adviser to Fabian

James Lewis

Tel: +44 20 7936 3000

KBC Peel Hunt - Joint Broker to Fabian

Capel Irwin

Tel: +44 20 7418 8900

Shore Capital Stockbrokers Limited - Joint Broker to Fabian

Dru Danford 

Tel: +44 20 7408 4090

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVBLBDGXGDGGIS
Date   Source Headline
2nd May 20247:00 amRNSInvestor presentation
30th Apr 20247:00 amRNSYear-end trading statement
16th Apr 20247:00 amRNSChange of auditor
15th Apr 20247:00 amRNSContract to develop a bespoke OptiPhage library
2nd Apr 20242:34 pmRNSBlock admission six monthly return
28th Mar 20245:00 pmRNSTotal Voting Rights
11th Mar 20243:04 pmRNSHolding(s) in Company
11th Mar 20249:10 amRNSHolding(s) in Company
8th Mar 20243:09 pmRNSHolding(s) in Company
5th Mar 202410:40 amRNSResult of General Meeting and Total Voting Rights
29th Feb 20245:00 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSFirst purchase order under MSA
14th Feb 20247:15 amRNSGrant of options and issue of shares to directors
14th Feb 20247:00 amRNSPlacing to raise £1,375,000
6th Feb 20247:00 amRNSFollow-on project award and R&D update
1st Feb 20247:00 amRNSHMRC R&D tax credit
4th Dec 202312:26 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSHalf-year Report
28th Nov 20237:00 amRNSOptiMAL collaboration agreement
9th Nov 20237:00 amRNSHalf year trading update
27th Oct 202311:57 amRNSResult of AGM
4th Oct 20232:45 pmRNSBlock admission six monthly return
29th Sep 20237:00 amRNSFinal Results
29th Aug 20237:00 amRNSUpdate on AI/ML-Ab service offering
24th Aug 20237:00 amRNSAppointment of interim CFO
21st Aug 20237:00 amRNSUpdate on AI/ML-Ab™ antibody discovery service
14th Aug 20237:00 amRNSUpdate on restructure and cost savings
30th Jun 20235:00 pmRNSTotal Voting Rights
16th Jun 202310:09 amRNSHolding(s) in Company
15th Jun 20239:45 amRNSHolding(s) in Company
13th Jun 20232:44 pmRNSHolding(s) in Company
12th Jun 20233:34 pmRNSHolding(s) in Company
12th Jun 202311:02 amRNSDirector/PDMR Shareholding
8th Jun 202310:39 amRNSResult of GM and total voting rights
31st May 20235:00 pmRNSTotal Voting Rights
26th May 20234:57 pmRNSHolding(s) in Company
26th May 20231:33 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResult of Retail Offer and Notice of GM
19th May 202310:01 amRNSREX Retail Offer
19th May 202310:00 amRNSPlacing, Subscription and Retail Offer
3rd Apr 20237:00 amRNSBlock listing Interim Review
31st Mar 20237:00 amRNSChange of Registered Office
21st Mar 20237:00 amRNSPatent application
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSTrading Statement
9th Feb 20237:00 amRNSR&D update: Mammalian Display service
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.